Revenue
2023
2024
2025
2026
Edx Medical Group plc (EDX)
Price£0.0900Cached quote
Financial statements
| 2026 | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
| Revenue | £330,541 | £122,608 | £227,986 | £3,864 |
| Research & development | £94,320 | £98,394 | N/A | N/A |
| Operating expenses | £5.6M | £4.3M | £3.3M | £3.6M |
| Operating income | −£5.7M | −£4.3M | −£3.3M | −£3.6M |
| Operating margin | −1,734.85% | −3,466.53% | −1,463.53% | −92,717.73% |
| EBITDA | −£5.5M | −£3.4M | −£3.5M | −£3.4M |
| EBITDA margin | −1,671.19% | −2,792.84% | −1,529.02% | −87,910.77% |
| Net income | −£5.8M | −£3.6M | −£3.8M | −£3.7M |
| Net profit margin | −1,741.99% | −2,931.61% | −1,645.68% | −95,998.01% |
| Basic EPSper basic share | N/A | -£0.01 | -£0.01 | -£0.01 |
| Diluted EPSper diluted share | N/A | -£0.01 | -£0.01 | -£0.01 |
Owners
Reported ownership